Skip to content
  • COMPANY
    • Expertise
      • Mission
      • Technology
      • Case Studies
        • Adenosine Receptor (A2A)
        • ABC Transporter (BmrA)
        • Bacteriorhodopsin
        • Bcl-2 Associated Athanogene 3 (BAG3)
        • K-Cl co-transporter 2 (KCC2)
        • Influenza A – H1N1 vaccinal preparation
        • Influenza Matrix Protein 2 (M2)
        • Voltage-gated Sodium Channel (Nav1.7)
      • Track Record
    • About Us
    • CALIXAR’s Partners
    • History
    • Business Model
    • Media
      • Press Releases
      • Related News
      • Events
  • PIPELINE
    • Undisclosed Ion Channel
    • Undisclosed Receptor
    • Adenosine receptor A2A
    • Melatonin receptor type 1A
    • Multidrug efflux pump subunit AcrB
    • Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
    • Solute carrier family 12 member 5
    • Vaccine Programs
      • HIV
      • Leptospirosis
      • Influenza
  • PRODUCTS
    • Purified Membrane Proteins
      • GPCRs
        • Adenosine receptor A2A
        • Melatonin receptor type 1A
        • Orphan GPCR
      • Ion Channels
        • Solute carrier family 12 member 5
      • Transporters
        • Multidrug efflux pump subunit AcrB
        • Multidrug resistance ABC transporter
          ATP-binding/permease protein BmrA
      • Vaccine Programs
        • HIV
        • Leptospirosis
        • Influenza
        • Chickungunya
    • Reagents and Kits
      • Proprietary Mild Detergents
        • CALX8
        • DDG
        • DDTAC
        • DLAC
        • FLAC6
        • ODG
      • Proprietary Stabilization Reagents
        • CALXGLUK
        • DDLAC
        • FTAC6
        • FTAC8
      • Kits
        • C2B Crystallization Kit
        • Solubilization & Stabilization Kit
  • SERVICES
    • Production
      • Expression
      • Isolation
    • Identification
      • Proteomic Studies
      • Target Identification
      • Ligand Identification
      • Understanding mechanism of action for targets or ligands
    • Structure Determination
      • Cryo EM studies
      • Crystallogenesis
      • Xray studies
      • 3D Structure Determination
    • Biological Assays
      • Ligand Binding Assays
      • Thermal Stability Assays
      • Structural Assays
      • Functional Assays
      • Stabilization Assays
  • APPLICATIONS
    • Drug Discovery
      • Deorphanization
      • Target Identification
      • Target Validation
      • High Throughput Screening (HTS)
      • Structure Based Drug Design (SBDD)
      • Fragment Based Drug Design (FBDD)
      • Structural Studies (Cryo EM, Xrays, etc)
    • Antibody Discovery
      • Phage Display
      • Yeast Display
      • Immunization
    • Vaccine Discovery
      • Antigen Discovery
      • Vaccine Formulation
      • Anti Bacterial Based Vaccine
      • Anti Viral Based Vaccine
      • Cell Based Vaccine
      • Subunit Antigen Vaccine
      • Split Virus Based Vaccine
    • Immunoassays
  • NEWS
  • CONTACT
Menu
  • COMPANY
    • Expertise
      • Mission
      • Technology
      • Case Studies
        • Adenosine Receptor (A2A)
        • ABC Transporter (BmrA)
        • Bacteriorhodopsin
        • Bcl-2 Associated Athanogene 3 (BAG3)
        • K-Cl co-transporter 2 (KCC2)
        • Influenza A – H1N1 vaccinal preparation
        • Influenza Matrix Protein 2 (M2)
        • Voltage-gated Sodium Channel (Nav1.7)
      • Track Record
    • About Us
    • CALIXAR’s Partners
    • History
    • Business Model
    • Media
      • Press Releases
      • Related News
      • Events
  • PIPELINE
    • Undisclosed Ion Channel
    • Undisclosed Receptor
    • Adenosine receptor A2A
    • Melatonin receptor type 1A
    • Multidrug efflux pump subunit AcrB
    • Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
    • Solute carrier family 12 member 5
    • Vaccine Programs
      • HIV
      • Leptospirosis
      • Influenza
  • PRODUCTS
    • Purified Membrane Proteins
      • GPCRs
        • Adenosine receptor A2A
        • Melatonin receptor type 1A
        • Orphan GPCR
      • Ion Channels
        • Solute carrier family 12 member 5
      • Transporters
        • Multidrug efflux pump subunit AcrB
        • Multidrug resistance ABC transporter
          ATP-binding/permease protein BmrA
      • Vaccine Programs
        • HIV
        • Leptospirosis
        • Influenza
        • Chickungunya
    • Reagents and Kits
      • Proprietary Mild Detergents
        • CALX8
        • DDG
        • DDTAC
        • DLAC
        • FLAC6
        • ODG
      • Proprietary Stabilization Reagents
        • CALXGLUK
        • DDLAC
        • FTAC6
        • FTAC8
      • Kits
        • C2B Crystallization Kit
        • Solubilization & Stabilization Kit
  • SERVICES
    • Production
      • Expression
      • Isolation
    • Identification
      • Proteomic Studies
      • Target Identification
      • Ligand Identification
      • Understanding mechanism of action for targets or ligands
    • Structure Determination
      • Cryo EM studies
      • Crystallogenesis
      • Xray studies
      • 3D Structure Determination
    • Biological Assays
      • Ligand Binding Assays
      • Thermal Stability Assays
      • Structural Assays
      • Functional Assays
      • Stabilization Assays
  • APPLICATIONS
    • Drug Discovery
      • Deorphanization
      • Target Identification
      • Target Validation
      • High Throughput Screening (HTS)
      • Structure Based Drug Design (SBDD)
      • Fragment Based Drug Design (FBDD)
      • Structural Studies (Cryo EM, Xrays, etc)
    • Antibody Discovery
      • Phage Display
      • Yeast Display
      • Immunization
    • Vaccine Discovery
      • Antigen Discovery
      • Vaccine Formulation
      • Anti Bacterial Based Vaccine
      • Anti Viral Based Vaccine
      • Cell Based Vaccine
      • Subunit Antigen Vaccine
      • Split Virus Based Vaccine
    • Immunoassays
  • NEWS
  • CONTACT
Search
Close

Home • News • Happy New Year 2022!

Happy New Year 2022!

  • January 4, 2022

Share on Facebook
Share on Twitter
Share on LinkedIn
PrevPrevious2nd Workshop on “Integrative Approach for a multi-scale understanding of Membrane Proteins Functions” (APPICOM) The “CALIXAR Poster Prize” has been awarded to Stephane Jedele.
NextCALIXAR v2.0: enhancing our agility by integrating digital technologies for better efficiency in and beyond 2022!Next

Contact us

Secure and boost your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.

  • Conformational antibody development
  • Vaccine development
  • High-throughput ligand screening
  • Structure-based drug discovery
  • Immunoassays
  • Deorphanization projects
  • Identification of relevant targets
  • Expression of full-length membrane proteins
  • Functional isolation and stabilization of targets

About

CALIXAR’s approach allows to preserve the original structure and function of membrane proteins (GPCRs, Ion Channels, Transporters, Receptors, Anchors and Viral Proteins) providing solutions for pharmaceutical industries, biotechnology companies and academic teams to develop conformational antibodies, formulate new vaccines, carry out Structure Based Drug Discovery and/or HTS assays.

Headquarters

  • Bâtiment Laennec
    60 avenue Rockefeller
    69008 Lyon - FRANCE
  • +33 481 076 460
  • contact(at)calixar.com

Links

Expertise

Company

Pipeline

Products

Services

Applications

Jobs

© 2020 Calixar. All rights reserved.

  • Legal notice
  • Sitemap
Linkedin-in Youtube